| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 27,405 | 25,971 | 19,085 | 28,327 | | Cost of Revenue | 20,777 | 19,739 | 14,023 | 20,218 | | | Gross Profit | 6,628 | 6,232 | 5,062 | 8,109 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,393 | 7,783 | 7,056 | 8,173 | | Non Recurring |
-
|
-
|
-
| 20,084 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (765) | (1,551) | (1,994) | (20,148) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 422 | 680 | (257) | (702) | | Earnings Before Interest And Taxes | (343) | (871) | (2,251) | (20,850) | | Interest Expense | 275 | 190 | 150 | 222 | | Income Before Tax | (618) | (1,061) | (2,401) | (21,072) | | Income Tax Expense | (109) | 8,840 | (786) | (297) | | Minority Interest |
-
| (2) |
-
| 3 | | | | Net Income From Continuing Ops | (509) | (9,903) | (1,615) | (20,772) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (509) | (9,903) | (1,615) | (20,772) | | Preferred Stock And Other Adjustments |
-
| 1 | (1) |
-
| | | Net Income Applicable To Common Shares | ($509) | ($9,902) | ($1,616) | ($20,772) |
|
0.51% Nasdaq 
Income Statement
